Parascript®, a leader in advanced data extraction from medical images, is exhibiting at the Radiological Society of North America (RSNA) 101st Scientific Assembly and Annual Meeting on November 29 through December 4, 2015.
Visit Booth 1739 to meet the Parascript® team in-person, get a demo, and enjoy giveaways.
This is a special event since RSNA 2015 celebrates 100 years of bringing together the radiology professionals for education, the latest in innovative technologies, and knowledge-sharing opportunities by practitioners and manufacturers.
Parascript® AccuDetect® is Computer-Aided Detection (CAD) for mammography. AccuDetect uses multiple independent cancer detection algorithms and a unique patented voting methodology to combine its findings. Comparing the results of the multiple image recognition processes allows for the mitigation of the inherent faults of the recognition processes, thus leading to improved sensitivity and reduced false-positive rates.
Per the study results published in Clinical Imaging (M. Lobbes et al., Clinical Imaging 37 (2013) 283-288), regarding the previous version of AccuDetect CAD, the system has shown better overall performance when compared to iCAD’s Second Look in detecting both soft tissue densities and calcifications. When compared to Second Look in extremely dense breasts (ACR 4), AccuDetect demonstrated 15.4 percent increase in detection of both masses and calcifications, and 14.6 percent increase in total cancer cases detection.
The U.S. Food and Drug Administration (FDA) has approved Parascript® AccuDetect® 7.0 for mammography systems manufactured by General Electric, Philips, Hologic, Fujifilm, Carestream, IMS, and Planmed. AccuDetect® is also CE marked and, in addition to the manufacturers listed above, it is compatible with Direct Radiography (DR) and Computed Radiography (CR) mammography systems from Agfa Healthcare, Allengers Medical Systems, and Siemens.
